Medical equipment and services company Steris (NYSE: STE). will be reporting earnings this Wednesday after market close. Here’s what investors should know.
STERIS met analysts’ revenue expectations last quarter, reporting revenues of $1.48 billion, up 4.3% year on year. It was a strong quarter for the company, with a narrow beat of analysts’ full-year EPS guidance estimates and a decent beat of analysts’ EPS estimates.
Is STERIS a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting STERIS’s revenue to grow 6.3% year on year to $1.36 billion, slowing from the 8.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.26 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. STERIS has missed Wall Street’s revenue estimates six times over the last two years.
Looking at STERIS’s peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. CONMED delivered year-on-year revenue growth of 3.1%, beating analysts’ expectations by 1.2%, and iRhythm reported revenues up 26.1%, topping estimates by 7.3%. CONMED traded up 1.8% following the results while iRhythm was also up 17.6%.
Read our full analysis of CONMED’s results here and iRhythm’s results here.
Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.3% on average over the last month. STERIS is down 2.1% during the same time and is heading into earnings with an average analyst price target of $268.50 (compared to the current share price of $228.43).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
